Clinical Trial Update: An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China

View source ↗

Summary

An ongoing observational study in China is evaluating real-world use of Upadacitinib tablets in adolescents and adults with moderate-to-severe atopic dermatitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Atopic Dermatitis | Status: RECRUITING